ArticlePCN reports : psychiatry and clinical neurosciences2025
Incidence and associated factors of delirium after hematopoietic stem cell transplantation: A retrospective study.
Article in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neuropsychiatric-pharmacologic synergy: interaction between psychiatric polypharmacy and cancer treatment-related neurotoxicity.Oxford medical case reports · 2026Article
- Incidence and associated factors of delirium after hematopoietic stem cell transplantation: A retrospective study.PCN reports : psychiatry and clinical neurosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: In general, delirium is reported to have a higher incidence in hospitalized patients and is associated with a higher risk of mortality. However, there is insufficient knowledge of the incidence and prognostic impact of delirium following hematopoietic stem cell transplantation. Therefore, we investigated the incidence of delirium after hematopoietic stem cell transplantation and to determine the relationship between delirium and associated factors. Methods: The study was a retrospective examination of the electronic medical records of 140 patients who underwent initial hematopoietic stem cell transplantation for hematologic cancers. The incidence of delirium occurring within 30 days of transplantation was assessed. We also examined its prognostic impact, pretransplantation risk factors, and association with graft-versus-host disease. Results: The incidence of delirium was 14.6%. Delirium was significantly associated with lower survival at 6 months posttransplant, but there was no significant effect of delirium on survival at 1 year or overall. A high or very high Disease Risk Index score was significantly associated with lower survival. Older age, a high or very high Disease Risk Index score, allogeneic transplantation, and lower oxygen saturation were identified as pretransplantation risk factors for delirium. A significant association was found between delirium and graft-versus-host disease. Conclusion: The incidence of delirium following hematopoietic stem cell transplantation is relatively high, and delirium is associated with short-term survival. When pretransplantation risk factors are present, thorough prevention and early detection of delirium are essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.